Published in Proteomics Weekly, April 5th, 2004
The data was presented by Dr. Christopher L. Reading, executive vice president of scientific development of Hollis-Eden, in an oral session at the Strategies for Immune Therapy Meeting in Wuerzburg, Germany.
Immune regulating hormones (IRHs) such as IMMUNITIN have previously been shown in preclinical and early clinical studies to reduce a wide...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly